In other developments, a federal court rejected, for now, the EPA’s move to rescind drinking-water limits for 4 PFAS ...

The UK pharmaceutical giant AstraZeneca is doubling down on its commitment to the Chinese drugmaker CSPC Pharmaceutical Group ...

Physicians of the Roman empire had a knack for making remedies from an assortment of components from various animals, ...

The new peer-reviewed journal aims to cover breakthroughs in nutritional science, technology, and engineering that contribute to human health ...

Venezuelan scientists are ‘waiting to see’ how damage to the country’s top basic science center will affect its research ...

For the fourth time, President Donald J. Trump has proposed eliminating the Chemical Safety and Hazard Investigation Board (CSB), an independent body that investigates the causes of significant ...

At the federal level, the Trump administration has shown a preference for voluntary action by industry over regulation. For ...

Continuing to battle against a hostile market environment, Dow says it plans to cut 4,500 jobs—13% of its workforce—as part ...

C&EN Reporter Delger Erdenesanaa discusses the trials and takeaways of the 30th annual United Nations climate summit ...

Oil spills rarely travel more than 300 km from their source before natural processes break them down. Ixtoc I, a 1979 spill ...

The Nature study, published in November 2023, attracted significant media attention because it claimed that an autonomous ...

The Swiss drug services firm Siegfried plans to acquire two small-molecule manufacturing sites in the US and one in Australia ...